by adminTorusBrand | Jul 18, 2013 | Scientific Research
[vc_row][vc_column][vc_column_text] Orrin Devinsky MD, Director of the Comprehensive Epilepsy Center at New York University, was recently awarded FDA approval to conduct a clinical trial that will study the safety and tolerability of cannabidiol (CBD) in children with...
by adminTorusBrand | Jul 15, 2013 | Scientific Research
Medical cannabis will be legalized in Ireland for the first time later this year, according to an article in the Irish Times. Specifically, the cannabidiol (CBD)/tetrahydrocannabinol (THC) drug Sativex will be able to be prescribed to help treat multiple sclerosis:...
by adminTorusBrand | Jul 12, 2013 | Scientific Research
Finally, hemp is getting the respect it deserves as a “superfood.” DietsInReview.com has the low-down on the new trend towards the nutrient-dense, incredibly nutritious plant: This particularly trusty strain of Cannabis has been besmirched by its illicit...
by adminTorusBrand | Jun 17, 2013 | Scientific Research
cannabidiol (CBD), the key cannabinoid component in dozens of Medical Marijuana, Inc. portfolio products. The University of Cologne in Germany conducted a study on the effectiveness of CBD versus standard anti-psychotics. PsychCentral.com outlines the results of this...
by adminTorusBrand | May 7, 2013 | Scientific Research
In a peer-reviewed study published in the British Journal of Pharmacology, several cannabinoids — including non-psychoactive cannabidiol (CBD), cannabigerol (CBG) and cannabidivarin (CBV) — appear to have the ability to “switch off”...
